Kardum, Željka
Prus, Višnja
Milas Ahić, Jasminka
Kardum, Darjan
Article History
Received: 27 February 2020
Accepted: 8 December 2020
First Online: 24 January 2021
Ethics approval and consent to participate
: The study was approved by University Hospital Osijek Ethics committee N<sup>o</sup> R2-1060/2020 and informed written consent was obtained.
: Written informed consent was obtained from the patient for publication of this case report. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: ŽK and VP has received speaker honorariums from Takeda Pharmaceuticals. DK owns stock in Takeda Pharmaceuticals. JMA declares that she has no conflict of interest.